Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
ArcelorMittal
MT
$55.3B
| $7.26M | ﹤0.01% |
276,986
-553,000
| -67% | -$13.6M |
|
1377
Lear
LEA
$8.18B
| $7.24M | ﹤0.01% |
58,397
+14,053
| +32% | +$1.86M |
|
1378
PUT
Trip.com Group
TCOM
$29.1B
| $7.22M | ﹤0.01% |
+210,000
| New | +$6.03M |
|
1379
Bright Horizons
BFAM
$3.86B
| $7.22M | ﹤0.01% |
114,404
+92,376
| +419% | +$6.05M |
|
|
ASBP
1380
Aspire Biopharma
ASBP
$10M
| $7.21M | ﹤0.01% |
583
| – | – |
|
1381
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $7.2M | ﹤0.01% |
96,813
| – | – |
|
1382
CALL
Devon Energy
DVN
$47.3B
| $7.18M | ﹤0.01% |
+116,800
| New | +$7.96M |
|
1383
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.9B
| $7.18M | ﹤0.01% |
45,238
+44,938
| +14,979% | +$7.15M |
|
1384
CALL
Uber
UBER
$153B
| $7.18M | ﹤0.01% |
290,200
+160,000
| +123% | +$4.38M |
|
1385
PUT
XPeng
XPEV
$11.6B
| $7.17M | ﹤0.01% |
+721,400
| New | +$6.5M |
|
|
BBBY
1386
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
| $7.16M | ﹤0.01% |
+2,851,700
| New | +$11.2M |
|
|
CIM
1387
Chimera Investment
CIM
$1B
| $7.14M | ﹤0.01% |
432,430
+379,868
| +723% | +$7.08M |
|
1388
Four Corners Property Trust
FCPT
$2.75B
| $7.13M | ﹤0.01% |
275,117
+3,329
| +1% | +$85.8K |
|
1389
Bank of Montreal
BMO
$127B
| $7.13M | ﹤0.01% |
78,715
+23,216
| +42% | +$2.15M |
|
1390
Thomson Reuters
TRI
$44.1B
| $7.11M | ﹤0.01% |
59,186
-36,477
| -38% | -$4.2M |
|
1391
PUT
Boston Beer
SAM
$1.92B
| $7.08M | ﹤0.01% |
21,500
-22,500
| -51% | -$8.16M |
|
1392
CALL
GSK
GSK
$106B
| $7.07M | ﹤0.01% |
+201,200
| New | +$6.7M |
|
1393
Huntsman Corp
HUN
$1.77B
| $7.06M | ﹤0.01% |
256,927
-3,465
| -1% | -$94.3K |
|
|
INN
1394
Summit Hotel Properties
INN
$700M
| $7.04M | ﹤0.01% |
974,693
+110,023
| +13% | +$862K |
|
|
SLVR
1395
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
| $7.03M | ﹤0.01% |
700,000
| – | – |
|
1396
CALL
Mohawk Industries
MHK
$9.22B
| $7.02M | ﹤0.01% |
+68,700
| New | +$6.74M |
|
1397
Olin
OLN
$2.12B
| $7.02M | ﹤0.01% |
132,623
-4,768
| -3% | -$253K |
|
1398
Unum
UNM
$14.3B
| $7.01M | ﹤0.01% |
170,851
-29,189
| -15% | -$1.22M |
|
1399
CALL
RTX Corp
RTX
$301B
| $7M | ﹤0.01% |
+69,400
| New | +$6.53M |
|
|
ELME
1400
Elme Communities
ELME
$144M
| $7M | ﹤0.01% |
393,410
+62,601
| +19% | +$1.15M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.